Reuters logo
BRIEF-Ra Pharmaceuticals posts Q3 loss of $0.68 per share
2017年11月9日 / 晚上9点33分 / 9 天前

BRIEF-Ra Pharmaceuticals posts Q3 loss of $0.68 per share

Nov 9 (Reuters) - Ra Pharmaceuticals Inc

* Ra pharmaceuticals reports third quarter 2017 financial results and provides corporate update

* Q3 loss per share $0.68

* Q3 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S

* As of September 30, 2017, Ra Pharma reported total cash and equivalents of $84.1 million​

* Company expects that its cash and cash equivalents will be sufficient to fund operations through end of 2018​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below